Literature DB >> 16771809

Kidney transplantation outcomes in Canadian aboriginals.

C L C Weber1, D N Rush, J R Jeffery, M Cheang, M E Karpinski.   

Abstract

Aboriginal populations experience a very high rate of end-stage renal disease (ESRD); however, little is known about the outcomes of transplantation in this population. We performed a retrospective database review to determine the short- and long-term outcomes of kidney transplantation in Aboriginals. Adult Aboriginal (AB) and Caucasian (C) individuals receiving primary kidney transplants between 1969 and 2003 in Manitoba, Canada were examined. A total of 705 recipients were included (126 AB and 579 C). AB recipients were younger, had different etiologies of ESRD, longer cold-ischemic times for deceased donor transplants, and higher peak panel reactive antibody levels. At 1 year post-transplant, there was no difference in serum creatinine, acute rejection or graft survival between AB and C recipients. However, AB recipients experienced greater weight gains early post-transplant and were more likely to develop post-transplant diabetes mellitus. AB recipients exhibited inferior 10-year graft (AB 26% vs. C 47%, p < 0.01) and patient survival (AB 50% vs. 75%, p < 0.01). When graft survival was censored for death with a functioning graft, there was no difference between the two groups. Multivariate analysis revealed AB race to be an independent predictor of premature graft failure and patient death. In conclusion, kidney transplant outcomes have historically been inferior in the Manitoba population of Canadian Aboriginals.

Entities:  

Mesh:

Year:  2006        PMID: 16771809     DOI: 10.1111/j.1600-6143.2006.01409.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  10 in total

Review 1.  The Global role of kidney transplantation.

Authors:  Guillermo Garcia Garcia; Paul Harden; Jeremy Chapman
Journal:  J Nephropathol       Date:  2012-07-01

2.  Liver transplant outcomes in a Canadian First Nations population.

Authors:  M Zhang; J Uhanova; G Y Minuk
Journal:  Can J Gastroenterol       Date:  2011-06       Impact factor: 3.522

3.  Dialysis and transplantation among Aboriginal children with kidney failure.

Authors:  Susan M Samuel; Bethany J Foster; Marcello A Tonelli; Alberto Nettel-Aguirre; Andrea Soo; R Todd Alexander; Lynden Crowshoe; Brenda R Hemmelgarn
Journal:  CMAJ       Date:  2011-05-24       Impact factor: 8.262

4.  Model for equitable care and outcomes for remote full care hemodialysis units.

Authors:  Keevin Bernstein; James Zacharias; James F Blanchard; B Nancy Yu; Souradet Y Shaw
Journal:  Clin J Am Soc Nephrol       Date:  2010-02-25       Impact factor: 8.237

5.  Association of modality with mortality among Canadian Aboriginals.

Authors:  Manish M Sood; Brenda Hemmelgarn; Claudio Rigatto; Paul Komenda; Karen Yeates; Steven Promislow; Julie Mojica; Navdeep Tangri
Journal:  Clin J Am Soc Nephrol       Date:  2012-09-20       Impact factor: 8.237

6.  The global role of kidney transplantation.

Authors:  G Garcia-Garcia; P Harden; J Chapman
Journal:  Indian J Nephrol       Date:  2012-03

7.  Comparative survival and economic benefits of deceased donor kidney transplantation and dialysis in people with varying ages and co-morbidities.

Authors:  Germaine Wong; Kirsten Howard; Jeremy R Chapman; Steven Chadban; Nicholas Cross; Allison Tong; Angela C Webster; Jonathan C Craig
Journal:  PLoS One       Date:  2012-01-18       Impact factor: 3.240

8.  Kidney transplant in Nigeria: a single centre experience.

Authors:  Umezurike Hughes Okafor
Journal:  Pan Afr Med J       Date:  2016-10-25

9.  Postoperative outcomes for Indigenous Peoples in Canada: a systematic review.

Authors:  Jason A McVicar; Alana Poon; Nadine R Caron; M Dylan Bould; Jason W Nickerson; Nora Ahmad; Donna May Kimmaliardjuk; Chelsey Sheffield; Caitlin Champion; Daniel I McIsaac
Journal:  CMAJ       Date:  2021-05-17       Impact factor: 8.262

10. 

Authors:  Jason A McVicar; Alana Poon; Nadine R Caron; M Dylan Bould; Jason W Nickerson; Nora Ahmad; Donna May Kimmaliardjuk; Chelsey Sheffield; Caitlin Champion; Daniel I McIsaac
Journal:  CMAJ       Date:  2021-08-23       Impact factor: 8.262

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.